{
  "ptid_time": "037_S_6377_2020-09-22",
  "img_path": "/data/qiuhui/data/adni/images/037_S_6377/2020-09-22/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,797 mm³, 0.5% below the reference mean. With a Z-score of -0.01 (49.5th percentile), this represents normal volume ; hippocampal volume measures 6,307 mm³, 2.9% below the reference mean. With a Z-score of -0.23 (40.8th percentile), this represents normal volume ; whole brain volume measures 900,674 mm³, 3.0% below the reference mean. With a Z-score of -0.36 (36.1th percentile), this represents normal volume ; entorhinal cortex volume measures 2,696 mm³, 22.1% below the reference mean. With a Z-score of -1.20 (11.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 16,012 mm³, 0.6% below the reference mean. With a Z-score of -0.05 (48.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,520 mm³, 13.9% below the reference mean. With a Z-score of -1.24 (10.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 83.6 years. Gender is Female. Education: 14 years. MMSE: 17.0. MoCA: 18.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Flobetaben (FBB): 1.52 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild atrophy in the entorhinal cortex and middle temporal gyrus, which are key regions affected in Alzheimer's disease. The MMSE (17) and MoCA (18) scores are significantly below normal, strongly suggesting cognitive impairment.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease given atrophy pattern and APOE4 carrier status).  \n\n**Confidence:** **High** (due to clear structural atrophy in AD-related regions and low cognitive scores).",
  "timestamp": "2025-07-26T06:55:24.124685"
}